The Development of UM-232, a Covalent STING Antagonist.

Barasa L, DeOrsey L, O'Reilly MD, Cahill SE, Choudhary S, Allabaji A, Vidadala SR, Sarkar SK, Patil SN, Hale J, Humphries F, Thompson PR

Open source

DOI
10.1021/acsmedchemlett.6c00114
Published
2026 Jul 9
Container
ACS medicinal chemistry letters
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsmedchemlett.6c00114,
  title = {The Development of UM-232, a Covalent STING Antagonist.},
  author = {Barasa L and DeOrsey L and O'Reilly MD and Cahill SE and Choudhary S and Allabaji A and Vidadala SR and Sarkar SK and Patil SN and Hale J and Humphries F and Thompson PR},
  year = {2026},
  journal = {ACS medicinal chemistry letters},
  doi = {10.1021/acsmedchemlett.6c00114},
  url = {https://doi.org/10.1021/acsmedchemlett.6c00114}
}

RIS

TY  - JOUR
TI  - The Development of UM-232, a Covalent STING Antagonist.
AU  - Barasa L
AU  - DeOrsey L
AU  - O'Reilly MD
AU  - Cahill SE
AU  - Choudhary S
AU  - Allabaji A
AU  - Vidadala SR
AU  - Sarkar SK
AU  - Patil SN
AU  - Hale J
AU  - Humphries F
AU  - Thompson PR
PY  - 2026
JO  - ACS medicinal chemistry letters
DO  - 10.1021/acsmedchemlett.6c00114
UR  - https://doi.org/10.1021/acsmedchemlett.6c00114
ER  - 

APA

L, B., L, D., MD, O., SE, C., S, C., A, A., SR, V., SK, S., SN, P., J, H., F, H., & PR, T. (2026). The Development of UM-232, a Covalent STING Antagonist.. ACS medicinal chemistry letters. https://doi.org/10.1021/acsmedchemlett.6c00114

Source records